The protective effect of quercetin and it nanocrystal on anxiety-like behaviors induced by animal model of Alzheimer’s disease Article Swipe
YOU?
·
· 2017
· Open Access
·
The protective effect of quercetin and it nanocrystal on anxiety-like behaviors induced by animal model of Alzheimer’s disease Introduction: Alzheimer is a neurodegenerative disease which is characterized by progressive memory loss, diminished cognitive ability and behavioral disturbances such as anxiety-like behaviors. Quercetin is polyphenolic compound with antioxidant and neuroprotective effects. Objective: Purpose of this study is evaluated antianxiety effect of quercetin and its nanocrystal in model of Alzheimer’s disease. Methods: In present study, 49 male rats were divided into 7 groups: control (normal untreated rats), sham (received distilled water orally and saline intrcerebroventriculary), disease (received 10µg/rat STZ and distilled water) and disease treated with quercetin and its nanocrystal groups (received quercetin and its nanocrystal at doses of 10 and 25 mg/kg of body weight per day orally for four weeks after injection of STZ). Model of Alzheimerchr('39')s disease induced by intracerebroventicular injection of STZ (icv-STZ) at doses of 10µg/rat. Elevated plus maze (EPM) test was used to assess anxiety-like behaviors. Results: Results indicated that icv-STZ injection significantly (P<0.001) decrease open arm times (%OAT) and open arm enters (%OAE) in the EPM test and in the groups treated with quercetin and its nanocrystal,these behavioral indexes significantly (P<0.001) increased in the end of third and fourth weeks. Also in disease treated quercetin nanocrystal groups showed a significant decrease in anxiety-like behaviors compare with the disease treated quercetin groups. Conclusion: The study demonstrates the effectiveness of quercetin and its nanocrystal in preventing the anxiogenic-like behaviors induced by Alzheimer’s model of rat. Also results show that treatment of alzheimerchr('39')s rat with quercetin nanocrystal is more effective than quercetin.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doaj.org/article/f7f5230425c944c19cfcc6887beb1b6a
- OA Status
- green
- Cited By
- 2
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4386623230
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4386623230Canonical identifier for this work in OpenAlex
- Title
-
The protective effect of quercetin and it nanocrystal on anxiety-like behaviors induced by animal model of Alzheimer’s diseaseWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2017Year of publication
- Publication date
-
2017-05-01Full publication date if available
- Authors
-
Akbar Hajizadeh Moghaddam, Mahboobeh Zare, S Rostamian, Sedigheh KhanjaniList of authors in order
- Landing page
-
https://doaj.org/article/f7f5230425c944c19cfcc6887beb1b6aPublisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doaj.org/article/f7f5230425c944c19cfcc6887beb1b6aDirect OA link when available
- Concepts
-
Disease, Nanocrystal, Anxiety, Quercetin, Psychology, Clinical psychology, Medicine, Materials science, Nanotechnology, Chemistry, Psychiatry, Internal medicine, Antioxidant, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 1, 2021: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4386623230 |
|---|---|
| doi | |
| ids.openalex | https://openalex.org/W4386623230 |
| fwci | 0.0 |
| type | article |
| title | The protective effect of quercetin and it nanocrystal on anxiety-like behaviors induced by animal model of Alzheimer’s disease |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T12023 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.6173999905586243 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2736 |
| topics[0].subfield.display_name | Pharmacology |
| topics[0].display_name | Cholinesterase and Neurodegenerative Diseases |
| topics[1].id | https://openalex.org/T13551 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.5253999829292297 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2737 |
| topics[1].subfield.display_name | Physiology |
| topics[1].display_name | Biochemical effects in animals |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2779134260 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6570559144020081 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[0].display_name | Disease |
| concepts[1].id | https://openalex.org/C175854130 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6461303234100342 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q98276914 |
| concepts[1].display_name | Nanocrystal |
| concepts[2].id | https://openalex.org/C558461103 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6091461777687073 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q154430 |
| concepts[2].display_name | Anxiety |
| concepts[3].id | https://openalex.org/C2781263971 |
| concepts[3].level | 3 |
| concepts[3].score | 0.4622625410556793 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q409478 |
| concepts[3].display_name | Quercetin |
| concepts[4].id | https://openalex.org/C15744967 |
| concepts[4].level | 0 |
| concepts[4].score | 0.41825783252716064 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q9418 |
| concepts[4].display_name | Psychology |
| concepts[5].id | https://openalex.org/C70410870 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3639870584011078 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q199906 |
| concepts[5].display_name | Clinical psychology |
| concepts[6].id | https://openalex.org/C71924100 |
| concepts[6].level | 0 |
| concepts[6].score | 0.3504706621170044 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[6].display_name | Medicine |
| concepts[7].id | https://openalex.org/C192562407 |
| concepts[7].level | 0 |
| concepts[7].score | 0.26113712787628174 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[7].display_name | Materials science |
| concepts[8].id | https://openalex.org/C171250308 |
| concepts[8].level | 1 |
| concepts[8].score | 0.20672118663787842 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11468 |
| concepts[8].display_name | Nanotechnology |
| concepts[9].id | https://openalex.org/C185592680 |
| concepts[9].level | 0 |
| concepts[9].score | 0.19680145382881165 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[9].display_name | Chemistry |
| concepts[10].id | https://openalex.org/C118552586 |
| concepts[10].level | 1 |
| concepts[10].score | 0.1556759476661682 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[10].display_name | Psychiatry |
| concepts[11].id | https://openalex.org/C126322002 |
| concepts[11].level | 1 |
| concepts[11].score | 0.13644197583198547 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[11].display_name | Internal medicine |
| concepts[12].id | https://openalex.org/C2778004101 |
| concepts[12].level | 2 |
| concepts[12].score | 0.06571429967880249 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q133948 |
| concepts[12].display_name | Antioxidant |
| concepts[13].id | https://openalex.org/C55493867 |
| concepts[13].level | 1 |
| concepts[13].score | 0.06157362461090088 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[13].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/disease |
| keywords[0].score | 0.6570559144020081 |
| keywords[0].display_name | Disease |
| keywords[1].id | https://openalex.org/keywords/nanocrystal |
| keywords[1].score | 0.6461303234100342 |
| keywords[1].display_name | Nanocrystal |
| keywords[2].id | https://openalex.org/keywords/anxiety |
| keywords[2].score | 0.6091461777687073 |
| keywords[2].display_name | Anxiety |
| keywords[3].id | https://openalex.org/keywords/quercetin |
| keywords[3].score | 0.4622625410556793 |
| keywords[3].display_name | Quercetin |
| keywords[4].id | https://openalex.org/keywords/psychology |
| keywords[4].score | 0.41825783252716064 |
| keywords[4].display_name | Psychology |
| keywords[5].id | https://openalex.org/keywords/clinical-psychology |
| keywords[5].score | 0.3639870584011078 |
| keywords[5].display_name | Clinical psychology |
| keywords[6].id | https://openalex.org/keywords/medicine |
| keywords[6].score | 0.3504706621170044 |
| keywords[6].display_name | Medicine |
| keywords[7].id | https://openalex.org/keywords/materials-science |
| keywords[7].score | 0.26113712787628174 |
| keywords[7].display_name | Materials science |
| keywords[8].id | https://openalex.org/keywords/nanotechnology |
| keywords[8].score | 0.20672118663787842 |
| keywords[8].display_name | Nanotechnology |
| keywords[9].id | https://openalex.org/keywords/chemistry |
| keywords[9].score | 0.19680145382881165 |
| keywords[9].display_name | Chemistry |
| keywords[10].id | https://openalex.org/keywords/psychiatry |
| keywords[10].score | 0.1556759476661682 |
| keywords[10].display_name | Psychiatry |
| keywords[11].id | https://openalex.org/keywords/internal-medicine |
| keywords[11].score | 0.13644197583198547 |
| keywords[11].display_name | Internal medicine |
| keywords[12].id | https://openalex.org/keywords/antioxidant |
| keywords[12].score | 0.06571429967880249 |
| keywords[12].display_name | Antioxidant |
| keywords[13].id | https://openalex.org/keywords/biochemistry |
| keywords[13].score | 0.06157362461090088 |
| keywords[13].display_name | Biochemistry |
| language | en |
| locations[0].id | pmh:oai:doaj.org/article:f7f5230425c944c19cfcc6887beb1b6a |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306401280 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | cc-by-sa |
| locations[0].pdf_url | |
| locations[0].version | submittedVersion |
| locations[0].raw_type | article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[0].is_accepted | False |
| locations[0].is_published | False |
| locations[0].raw_source_name | Journal of Medicinal Plants, Vol 16, Iss 62, Pp 158-168 (2017) |
| locations[0].landing_page_url | https://doaj.org/article/f7f5230425c944c19cfcc6887beb1b6a |
| indexed_in | doaj |
| authorships[0].author.id | https://openalex.org/A5075970055 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0843-8440 |
| authorships[0].author.display_name | Akbar Hajizadeh Moghaddam |
| authorships[0].countries | IR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4871159 |
| authorships[0].affiliations[0].raw_affiliation_string | University of Mazandaran |
| authorships[0].institutions[0].id | https://openalex.org/I4871159 |
| authorships[0].institutions[0].ror | https://ror.org/05fp9g671 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I4871159 |
| authorships[0].institutions[0].country_code | IR |
| authorships[0].institutions[0].display_name | University of Mazandaran |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | A Hajizadeh |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | University of Mazandaran |
| authorships[1].author.id | https://openalex.org/A5087099899 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-1697-3638 |
| authorships[1].author.display_name | Mahboobeh Zare |
| authorships[1].countries | IR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210125640 |
| authorships[1].affiliations[0].raw_affiliation_string | Faculty of Herb, Amol University of Special Modern Technologies, Amol, Iran |
| authorships[1].institutions[0].id | https://openalex.org/I4210125640 |
| authorships[1].institutions[0].ror | https://ror.org/02twggb97 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210125640 |
| authorships[1].institutions[0].country_code | IR |
| authorships[1].institutions[0].display_name | Amol University of Special Modern Technologies |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | M Zare |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Faculty of Herb, Amol University of Special Modern Technologies, Amol, Iran |
| authorships[2].author.id | https://openalex.org/A5109753356 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | S Rostamian |
| authorships[2].countries | IR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4871159 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Biology, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran |
| authorships[2].institutions[0].id | https://openalex.org/I4871159 |
| authorships[2].institutions[0].ror | https://ror.org/05fp9g671 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I4871159 |
| authorships[2].institutions[0].country_code | IR |
| authorships[2].institutions[0].display_name | University of Mazandaran |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | S Rostamian |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Biology, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran |
| authorships[3].author.id | https://openalex.org/A5020571350 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Sedigheh Khanjani |
| authorships[3].countries | IR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I48379061 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Physiology, Faculty of Biology Sciences, Shahid Beheshti University, Tehran, Iran |
| authorships[3].institutions[0].id | https://openalex.org/I48379061 |
| authorships[3].institutions[0].ror | https://ror.org/0091vmj44 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I48379061 |
| authorships[3].institutions[0].country_code | IR |
| authorships[3].institutions[0].display_name | Shahid Beheshti University |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | S Khanjani |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Physiology, Faculty of Biology Sciences, Shahid Beheshti University, Tehran, Iran |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doaj.org/article/f7f5230425c944c19cfcc6887beb1b6a |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | The protective effect of quercetin and it nanocrystal on anxiety-like behaviors induced by animal model of Alzheimer’s disease |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T04:12:42.849631 |
| primary_topic.id | https://openalex.org/T12023 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.6173999905586243 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2736 |
| primary_topic.subfield.display_name | Pharmacology |
| primary_topic.display_name | Cholinesterase and Neurodegenerative Diseases |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W2165343866, https://openalex.org/W2326629460, https://openalex.org/W2472360598, https://openalex.org/W3022959415, https://openalex.org/W2527566098, https://openalex.org/W1007235230, https://openalex.org/W2771376473, https://openalex.org/W2013721540 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2021 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | pmh:oai:doaj.org/article:f7f5230425c944c19cfcc6887beb1b6a |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306401280 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | cc-by-sa |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-sa |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Journal of Medicinal Plants, Vol 16, Iss 62, Pp 158-168 (2017) |
| best_oa_location.landing_page_url | https://doaj.org/article/f7f5230425c944c19cfcc6887beb1b6a |
| primary_location.id | pmh:oai:doaj.org/article:f7f5230425c944c19cfcc6887beb1b6a |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306401280 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | cc-by-sa |
| primary_location.pdf_url | |
| primary_location.version | submittedVersion |
| primary_location.raw_type | article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-sa |
| primary_location.is_accepted | False |
| primary_location.is_published | False |
| primary_location.raw_source_name | Journal of Medicinal Plants, Vol 16, Iss 62, Pp 158-168 (2017) |
| primary_location.landing_page_url | https://doaj.org/article/f7f5230425c944c19cfcc6887beb1b6a |
| publication_date | 2017-05-01 |
| publication_year | 2017 |
| referenced_works_count | 0 |
| abstract_inverted_index.7 | 79 |
| abstract_inverted_index.a | 21, 213 |
| abstract_inverted_index.10 | 117 |
| abstract_inverted_index.25 | 119 |
| abstract_inverted_index.49 | 73 |
| abstract_inverted_index.In | 70 |
| abstract_inverted_index.as | 38 |
| abstract_inverted_index.at | 114, 145 |
| abstract_inverted_index.by | 12, 27, 139, 243 |
| abstract_inverted_index.in | 64, 178, 183, 197, 206, 216, 237 |
| abstract_inverted_index.is | 20, 25, 42, 55, 259 |
| abstract_inverted_index.it | 6 |
| abstract_inverted_index.of | 3, 15, 52, 59, 66, 116, 121, 132, 135, 142, 147, 200, 232, 246, 253 |
| abstract_inverted_index.on | 8 |
| abstract_inverted_index.to | 156 |
| abstract_inverted_index.EPM | 180 |
| abstract_inverted_index.STZ | 96, 143 |
| abstract_inverted_index.The | 0, 227 |
| abstract_inverted_index.and | 5, 34, 47, 61, 90, 97, 100, 105, 111, 118, 173, 182, 189, 202, 234 |
| abstract_inverted_index.arm | 170, 175 |
| abstract_inverted_index.day | 125 |
| abstract_inverted_index.end | 199 |
| abstract_inverted_index.for | 127 |
| abstract_inverted_index.its | 62, 106, 112, 190, 235 |
| abstract_inverted_index.per | 124 |
| abstract_inverted_index.rat | 255 |
| abstract_inverted_index.the | 179, 184, 198, 221, 230, 239 |
| abstract_inverted_index.was | 154 |
| abstract_inverted_index.Also | 205, 248 |
| abstract_inverted_index.body | 122 |
| abstract_inverted_index.four | 128 |
| abstract_inverted_index.into | 78 |
| abstract_inverted_index.male | 74 |
| abstract_inverted_index.maze | 151 |
| abstract_inverted_index.more | 260 |
| abstract_inverted_index.open | 169, 174 |
| abstract_inverted_index.plus | 150 |
| abstract_inverted_index.rat. | 247 |
| abstract_inverted_index.rats | 75 |
| abstract_inverted_index.sham | 85 |
| abstract_inverted_index.show | 250 |
| abstract_inverted_index.such | 37 |
| abstract_inverted_index.test | 153, 181 |
| abstract_inverted_index.than | 262 |
| abstract_inverted_index.that | 163, 251 |
| abstract_inverted_index.this | 53 |
| abstract_inverted_index.used | 155 |
| abstract_inverted_index.were | 76 |
| abstract_inverted_index.with | 45, 103, 187, 220, 256 |
| abstract_inverted_index.(EPM) | 152 |
| abstract_inverted_index.Model | 134 |
| abstract_inverted_index.STZ). | 133 |
| abstract_inverted_index.after | 130 |
| abstract_inverted_index.doses | 115, 146 |
| abstract_inverted_index.loss, | 30 |
| abstract_inverted_index.mg/kg | 120 |
| abstract_inverted_index.model | 14, 65, 245 |
| abstract_inverted_index.study | 54, 228 |
| abstract_inverted_index.third | 201 |
| abstract_inverted_index.times | 171 |
| abstract_inverted_index.water | 88 |
| abstract_inverted_index.weeks | 129 |
| abstract_inverted_index.which | 24 |
| abstract_inverted_index.(%OAE) | 177 |
| abstract_inverted_index.(%OAT) | 172 |
| abstract_inverted_index.animal | 13 |
| abstract_inverted_index.assess | 157 |
| abstract_inverted_index.effect | 2, 58 |
| abstract_inverted_index.enters | 176 |
| abstract_inverted_index.fourth | 203 |
| abstract_inverted_index.groups | 108, 185, 211 |
| abstract_inverted_index.memory | 29 |
| abstract_inverted_index.orally | 89, 126 |
| abstract_inverted_index.rats), | 84 |
| abstract_inverted_index.saline | 91 |
| abstract_inverted_index.showed | 212 |
| abstract_inverted_index.study, | 72 |
| abstract_inverted_index.water) | 99 |
| abstract_inverted_index.weeks. | 204 |
| abstract_inverted_index.weight | 123 |
| abstract_inverted_index.(normal | 82 |
| abstract_inverted_index.Purpose | 51 |
| abstract_inverted_index.Results | 161 |
| abstract_inverted_index.ability | 33 |
| abstract_inverted_index.compare | 219 |
| abstract_inverted_index.control | 81 |
| abstract_inverted_index.disease | 17, 23, 93, 101, 137, 207, 222 |
| abstract_inverted_index.divided | 77 |
| abstract_inverted_index.groups. | 225 |
| abstract_inverted_index.groups: | 80 |
| abstract_inverted_index.icv-STZ | 164 |
| abstract_inverted_index.indexes | 193 |
| abstract_inverted_index.induced | 11, 138, 242 |
| abstract_inverted_index.present | 71 |
| abstract_inverted_index.results | 249 |
| abstract_inverted_index.treated | 102, 186, 208, 223 |
| abstract_inverted_index.Elevated | 149 |
| abstract_inverted_index.Methods: | 69 |
| abstract_inverted_index.Results: | 160 |
| abstract_inverted_index.compound | 44 |
| abstract_inverted_index.decrease | 168, 215 |
| abstract_inverted_index.disease. | 68 |
| abstract_inverted_index.effects. | 49 |
| abstract_inverted_index.(P<0.001) | 167, 195 |
| abstract_inverted_index.(icv-STZ) | 144 |
| abstract_inverted_index.(received | 86, 94, 109 |
| abstract_inverted_index.10µg/rat | 95 |
| abstract_inverted_index.Alzheimer | 19 |
| abstract_inverted_index.Quercetin | 41 |
| abstract_inverted_index.behaviors | 10, 218, 241 |
| abstract_inverted_index.cognitive | 32 |
| abstract_inverted_index.distilled | 87, 98 |
| abstract_inverted_index.effective | 261 |
| abstract_inverted_index.evaluated | 56 |
| abstract_inverted_index.increased | 196 |
| abstract_inverted_index.indicated | 162 |
| abstract_inverted_index.injection | 131, 141, 165 |
| abstract_inverted_index.quercetin | 4, 60, 104, 110, 188, 209, 224, 233, 257 |
| abstract_inverted_index.treatment | 252 |
| abstract_inverted_index.untreated | 83 |
| abstract_inverted_index.10µg/rat. | 148 |
| abstract_inverted_index.Objective: | 50 |
| abstract_inverted_index.behavioral | 35, 192 |
| abstract_inverted_index.behaviors. | 40, 159 |
| abstract_inverted_index.diminished | 31 |
| abstract_inverted_index.preventing | 238 |
| abstract_inverted_index.protective | 1 |
| abstract_inverted_index.quercetin. | 263 |
| abstract_inverted_index.Conclusion: | 226 |
| abstract_inverted_index.antianxiety | 57 |
| abstract_inverted_index.antioxidant | 46 |
| abstract_inverted_index.nanocrystal | 7, 63, 107, 113, 210, 236, 258 |
| abstract_inverted_index.progressive | 28 |
| abstract_inverted_index.significant | 214 |
| abstract_inverted_index.anxiety-like | 9, 39, 217 |
| abstract_inverted_index.demonstrates | 229 |
| abstract_inverted_index.disturbances | 36 |
| abstract_inverted_index.polyphenolic | 43 |
| abstract_inverted_index.Alzheimer’s | 16, 67, 244 |
| abstract_inverted_index.Introduction: | 18 |
| abstract_inverted_index.characterized | 26 |
| abstract_inverted_index.effectiveness | 231 |
| abstract_inverted_index.significantly | 166, 194 |
| abstract_inverted_index.anxiety-like | 158 |
| abstract_inverted_index.anxiogenic-like | 240 |
| abstract_inverted_index.neuroprotective | 48 |
| abstract_inverted_index.nanocrystal,these | 191 |
| abstract_inverted_index.neurodegenerative | 22 |
| abstract_inverted_index.Alzheimerchr('39')s | 136 |
| abstract_inverted_index.alzheimerchr('39')s | 254 |
| abstract_inverted_index.intracerebroventicular | 140 |
| abstract_inverted_index.intrcerebroventriculary), | 92 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| citation_normalized_percentile.value | 0.35477744 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |